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Hannu Haapasalo3,4 and Bjarne Udd2,3,6,7
Abstract
Introduction: Limb girdle muscular dystrophies are a large group of both dominantly and recessively inherited
muscle diseases. LGMD1D is caused by mutated DNAJB6 and the molecular pathogenesis is mediated by defective
chaperonal function leading to impaired handling of misfolded proteins which normally would be degraded. Here
we aim to clarify muscle pathology of LGMD1D in order to facilitate diagnostic accuracy.
After following six Finnish LGMD1D families, we analysed 21 muscle biopsies obtained from 15 patients at different
time points after the onset of symptoms. All biopsies were obtained from the lower limb muscles and processed
for routine histochemistry, extensive immunohistochemistry and electron microscopy.
Results: Histopathological findings were myopathic or dystrophic combined with rimmed vacuolar pathology, and
small myofibrillar aggregates. These myofibrillar inclusions contained abnormal accumulation of a number of
proteins such as myotilin, αB-crystallin and desmin on immunohistochemistry, and showed extensive myofibrillar
disorganization with excess of Z-disk material on ultrastructure. Later in the disease process the rimmed vacuolar
pathology dominated with rare cases of pronounced larger pleomorphic myofibrillar aggregates. The rimmed
vacuoles were reactive for several markers of defect autophagy such as ubiquitin, TDP-43, p62 and SMI-31.
Conclusions: Since DNAJB6 is known to interact with members of the chaperone assisted selective autophagy
complex (CASA), including BAG3 – a known myofibrillar myopathy causing gene, the molecular muscle pathology
is apparently mediated through impaired functions of CASA and possibly other complexes needed for the
maintenance of the Z-disk and sarcomeric structures. The corresponding findings on histopathology offer clues for
the diagnosis.
Keywords: LGMD1D, DNAJB6, Myopathy, Autophagy, CASA
Introduction
Limb girdle muscular dystrophy (LGMD) 1D is an auto-
somal dominant myopathy usually with late onset of weak-
ness at the age of 30–60 and slow progression, although
more aggressive forms can occur [1]. The disease affects
mainly the lower limb muscles with a particular pattern of
preferential involvement [2]. Typically the first symptom is
difficulty in climbing stairs. Loss of ambulation does not
occur until late senescence, except for the aggressive form
of the disease [3]. Some patients may suffer from dysphagia
or dysarthria. Phenotype descriptions and families from
different ethnic populations have been reported [4, 5].
Myofibrillar myopathies (MFMs) are a group of myop-
athies that share common morphological findings but
have different molecular etiologies [6, 7]. MFMs are
characterized by a distinct pathological pattern of dark
and hyaline cytoplasmic changes on trichrome staining
corresponding to myofibrillar dissolution and accumula-
tion of myofibrillar aggregates causing accumulated
expression of several proteins, including desmin, myoti-
lin, alphaB-crystallin and occasional amyloid material.
On electron microscopy pathological alterations are
marked in Z-disc structures leading to Z-line streaming
and dispersion of dark Z-disc components [8]. A novel
term: Protein aggregate and vacuolar myopathy, comprises
a larger spectrum of myopathies unified by their patho-
logical features, including the myofibrillar myopathies and
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Table 1 Clinical summary
Patient Sex Age of onset Age at muscle biopsy Symptoms (when examined) CK EMG Other
FF1
III-6 M 50 74 ll severe, ul mild 400 na
III-8 F 60 69 ll mild, ul mild 187 myopathic
III-12 F 35 47, 63, 72 ll severe, ul moderate 338 myopathic
IV-7 M 34 46, 48 ll moderate, ul moderate 789 myopathic dysphagia
V-8 M 30 38 ll mild, no ul 820 myopathic
IV-9 F 30 38, 42 ll moderate, ul mild 375 myopathic
IV-10 M 20 44, 49 ll moderate, ul mild 175 myopathic
FF2
III-4 F 50 63 ll mild, no ul 520 myopathic
FF3
IV-1 M 38 49, 51 ll, severe, ul moderate 600 myopathic dysarthria, ll pain
FF4
III-2 F 40 62 ll mild, slow course “normal” myopathic
IV-1 M 28 31 ll mild, ul mild 1900 myopathic
FF5
IV-1 M 30 47 ll severe, ul mild “normal” myopathic dysphagia
FF6
IV-1 M 40 51 ll, severe, ul moderate 800 myopathic
ll, lower limb; ul, upper limb. Clinical findings at the time of clinical examination, within one year of muscle biopsy sample time (or latest biopsy, if many). Creatine
kinase (CK) normal upper limits 400 for men, 210 for women
Fig. 1 Pedigrees of Finnish families FF1–6. Black figures represent affected individuals
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various rimmed vacuolar myopathies with protein aggre-
gates or inclusions [9].
We have previously reported preliminary data on muscle
biopsy findings in patients with p.F93L mutation in DNAJB6
[1, 10] and Sato et al. have reported biopsy findings in five
LGMD1D patients [11] with the p.F93I mutation. In our
current study of a large biopsy material of LGMD1D
patients we show consistent pathological changes in the
routine histopathology that can be used to direct the
molecular genetic confirmation of the final diagnosis. More-
over, we show that the abnormal protein accumulations
follow a sequential evolution from the early stage of small
central myofibrillar lesions to the later stage of widespread
myofibrillar disintegration with and autophagic rimmed
vacuolar pathology in atrophic degenerating fibers.
Materials and methods
15 patients from six unrelated Finnish families were stud-
ied, four of them had two and one patient three biopsies,
with an age range from 47 to 78 years. Patient data and
their clinical findings are presented in Table 1. Clinical
examination data was available from 13 patients. All pa-
tients were heterozygous for the DNAJB6 mutation p. F93L.
Pedigrees of the families FF1–6 are presented in Fig. 1.
All together 21 muscle biopsy samples were collected
from four anatomically different muscles (vastus lateralis
(VL), gluteus (G), soleus (S) and gastrocnemius medialis
(GM)). Fresh-frozen 10 μm cryostat sections of muscle
tissue were stained with routine histochemical tech-
niques [12, 13]. Frozen sections of 6 μm thickness were
cut and mounted on superFrost plus slides. Immunohis-
tochemical staining was performed with the Ventana
BechMark immunoautomate (Roche Tissue Diagnostics,
Inc. AZ 85755) with antibodies and dilutions detailed in
Table 2. The immunoreactions were visualized with a
Ventana peroxidase based detection kit (UltraView
Universal DAB detection system kit, Roche Tissue Diag-
nostics, Inc. AZ 85755). Stained sections were dehydrated
using a gradient of ethanol and xylene and mounted with
a solvent based mounting media.
Antibodies applied for immunohistochemical stainings
are detailed in Table 2.
Ultrastructural studies were performed on ten patients.
Muscle specimens were processed for semithin and
ultrathin sections according to standard methods [14]
and examined with JEOL 1400 transmission electron
microscope (JEOL, Japan). Electron micrographs were
taken by Olympus-SIS Morada digital camera (Olympus
Soft Imaging Solutions, Munster, Germany).
Results
Clinical summary of the patients is presented in Table 1.
On light microscopy general myopathic or dystrophic
features of variable severity depending on the stage of
the disease were observed in all cases: fibrosis and fatty
replacement of the muscle tissue, fiber size variation
with atrophic and occasional hypertrophic fibers and
central nucleation (Fig. 2a, b). There were occasional
split fibers, necrotic and regenerating fibers, as well as
focal endomysial mononuclear cells (Table 3). A uniform
microscopic finding was the presence of distinct areas of
myofibrillar abnormalities. In addition, rimmed vacuolar
pathology was found in all cases. In the early stage path-
ology the myofibrillar lesions were characteristically
Table 2 Antibodies used in immunohostochemical stainings,
their dilutions and supplier
Antibody Dilution Supplier
Myotilin 1:50 Leica Biosystems, Novocastra
Alpha B crystallin 1:10 Leica Biosystems, Novocastra
Desmin 1:800 Biogenex
Dystrophin 2 (c-terminus) 1:100 Leica Biosystems, Novocastra
SMI-31 1:1000 Biosite
SMI-310 1:400 Abcam
TDP-43 1:175 Proteintech Europe
P62 (SQSTM1) 1:100 Santa Cruz Biotechnology
Ubiquitin 1:300 Dako
LAMP2 1:50 Southern Biotech
LC3 1:50 Novus Biologicals
LC3B 1:50 Cell Signaling technology
VCP 1:600 Thermo Scientific
FHL-1 1:200 Lifespan biosciences
DNAJB6 1:100 Abnova
HSPB8 1:200 Abcam
BAG3 1:800 Proteintech Europe
Proteasome 1:30 Atlas antibodies
Beta-amyloid 1:30 Leica Biosystems, Novocastra
Life
Amyloid precursor protein 1:50 Biosciences
Wip1 1:50 Sigma
Dystrophin 1 (rod domain) 1:40 Leica Biosystems, Novocastra
Dystrophin 2 (c-terminus) 1:100 Leica Biosystems, Novocastra
Dystrophin 3 (N-terminus) 1:20 Leica Biosystems, Novocastra
Dysferlin 1:200 Leica Biosystems, Novocastra
α-Sarcoglycan 1:100 Leica Biosystems, Novocastra
β-Sarcoglycan 1:100 Leica Biosystems, Novocastra
γ-Sarcoglycan 1:15 Leica Biosystems, Novocastra
α-Dystroglycan 1:200 Millipore, Upstate
Caveolin 3 1:150 Santa Cruz Biotechnology
Merosin Laminin Alpha 2
Chain
1:500 USBiological
Utrophin 1:20 Leica Biosystems, Novocastra
Spectrin 1:50 Leica Biosystems, Novocastra
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small in size and often in a few fibers only, making them
difficult to distinguish. On transverse sections they ap-
peared as rounded dense aggregates on H&E staining
and were often more easily identified on the modified
trichrome stain as dark green areas. In these regions
oxidative enzyme stainings were often weak, however
without very distinct core or rubbed-out pathology. On
longitudinal sections the myofibrillar lesions were wavy
in shape extending over several sarcomeres in length.
They occurred mainly in fibers with normal caliber and
were usually not located in the periphery of the fibers.
Both fiber types were equally involved. In the late stage
of the disease the rimmed vacuolar pathology was
usually very prominent. In a single biopsy a large num-
ber of fibers containing pleomorphic hyaline myofibrillar
masses reminiscent of a classic myofibrillar myopathy
were seen (Fig. 3a). These pleomorphic regions were oc-
casionally congophilic on Congo red staining appearing
bright red visualized through Texas red fluorescent
filters (Fig. 3b). Increased expression of beta-amyloid
precursor protein (APP) was also observed in some of
these fiber regions associated with the hyaline deposits.
On immunohistochemistry moderate or strong expression
of several proteins including myotilin, desmin, alphaB-
crystallin, proteasome and SMI310 were shown in the myo-
fibrillar lesions with aggregates (Fig. 3a, c, d) (Table 4), and
dystrophin showed ectopic expression of mild or moderate
intensity in the same regions (Fig. 3e). The extent of the ag-
gregate pathology was variable depending on the stage of
the disease. The protein accumulations also contained all
tested CASA complex proteins such as BAG3, heat shock
protein (HSP) B8, and DNAJB6 itself (Fig. 3f, g, h). The
rimmed vacuoles showed material with reactivity for
several markers of defect degradation and autophagic
processing such as ubiquitin, valosin-containing pro-
tein (VCP), TDP-43, p62 and SMI-31 (Table 4)
(Fig. 4a, b, c, d, e). These rimmed vacuolar regions of
local degeneration were filled with autophagosomes as
shown by LC3 reactivity, whereas components of ma-
ture lysosomes expressing LAMP2 were less abundant
or absent in the rimmed vacuolar spaces (Fig. 4f, g).
Antibodies applied for the sarcolemmal proteins
showed normal findings in the sarcolemma (Table 2).
On electron microscopy the myofibrillar lesions
showed severe structural sarcomere disarrangement as-
sociated with prominent excess and dispersion of disin-
tegrated Z-disk material (Fig. 5). Other frequent findings
included autophagic regions with vesicles, myeloid fig-
ures and debris material, and fibers with multiple small
vacuoles appearing to arise from the sarcoplasmic
reticulum. A rare finding was the presence of occasional
tubulofilamentous intranuclear or cytoplasmic inclusions
in two cases.
Discussion and conclusions
The muscle pathology in our study of DNAJB6 mutated
LGMD1D shows distinct findings that should provide
clues for a correct diagnostic approach even in a spor-
adic patient without known family history. On light mi-
croscopy the most common finding is the presence of
early stage myofibrillar disintegration with small myofi-
brillar aggregates and rimmed vacuolated fibers. On im-
munohistochemistry many proteins are found in the
aggregates, and the rimmed vacuoles are reactive for
several proteins associated with autophagy. The light
microscopy findings are in general similar to MFMs.
However, the myofibrillar aggregates are commonly dis-
tributed in scattered fibers and are smaller than in a
Fig. 2 a On H&E staining on gastrocnemius lateralis muscle of a 51-year-old male (FF3, IV-1) mild endomysial fibrosis as well as fiber size variation,
internal nuclei, one atrophic rimmed vacuolated fiber (arrow in the middle) and small centrally located myofibrillar aggregates mainly in non-atrophic
fibers (arrows in left corner) are evident. b. In modified trichrome staining of the same muscle the aggregates appear as darker stained areas
Sandell et al. Acta Neuropathologica Communications  (2016) 4:9 Page 4 of 10
Table 3 Myopathological findings
Muscle Neurogenic
fiber type
grouping
Fiber type
predominance
Fiber size
variation
Fibrosis and
fatty
degeneration
Increase of
internal
nuclei
Fiber
splitting
Necrosis Lymphocyte
infiltrates
Fiber
regeneration
Rimmed
vacuoles
Cytoplasmic
myofibrillar
inclusions
Core-
like
lesions
Rubbed-
out fibers
Moth-
eaten
Lobulated
fibers
Ragged
red fibers
COX– fibers
FF1
III-6 VL – + ++ + + – – – + + + – ++ + – –
III-8 S (+) – ++ ++ ++ ++ – – + ++ ++ – – – – –
III-12 VL – + (+) + – – – – + (+) + – – – – –
GLU – + (+) + – + – + + + ++ + – – – –
VL – (+) + + – + + + + ++ – – + – – –
IV-7 GM – – + + + + + + – + + +++ – – – – –
GM – – ++ ++ ++ ++ – + + ++ ++ + – + – – –
IV-8 GM – – + – + + + + + + + + – + + – –
IV-9 VL – + + – + + + + + + + – – + – – –
VL + – ++ + + – – – – + + – – – (+) – (+)
IV-10 VL – – – – – – – – – + (+) + – – – – –
VL – + + – + – – – – + + + – – – – –
FF2
III-4 VL – + – + – – – – + + – – – – – (+)
III-5 VL – + – + – – – – + ++ – – – – – (+)
III-7 VL – ++ ++ +++ + + + + + + + – + – – –
FF3
IV-1 VL + – ++ + +++ + + + – + ++ + – + – – –
GL – – ++ + ++ + ++ + – + ++ ++ – + + – (+)
FF4
III-2 VL – + ++ ++ ++ + + – – + + + – + – – –
IV-1 VL – – (+) – + – + – + + + ++ – + – – –
FF5
IV-1 VL – + ++ ++ ++ + + + – ++ + + – – +++ – –
FF6
IV-1 VL + – ++ ++ + – – – – + + – – + + – (+)
Internal nuclei amount assessed as: –, absent; (+), existent in < 1 %; +, existent up to 5 %; ++, existent in 6–20 %; +++, existent in over 20 % of the fibers. Fibrosis and fatty degeneration: –, no fibrosis, fatty
degeneration; +, mildly increased; ++, moderately increased
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typical MFM. Only in one biopsy large and pleomorphic
aggregates in groups of fibers unevenly distributed
across the fascicles more characteristic of a typical
MFM were seen. In addition, rubbed-out fibers com-
monly found in MFMs such as desminopathies and
alphaB-crystallinopathies are not a common feature in
LGMD1D.
Secondary inflammatory changes that often may occur
in genetic myopathies were observed in approximately
half of the DNAJB6 mutant biopsies. However, the endo-
mysial inflammatory cells were few in number without
larger infiltrates and no invasion in non-necrotic fibers
was observed. In addition, there was no significant ex-
pression of MHC HLA Class I, thus clearly preventing
any confusion with sporadic inclusion body myositis (s-
IBM) despite the rimmed vacuolation. In addition, no
significant numbers of cytochrome oxidase-negative
muscle fibers or ragged red fibers were present. Clinic-
ally, the involvement of hamstrings was always more se-
vere than the quadriceps and without the finger flexor
weakness as with s-IBM.
The ultrastructural findings in myofibrillar myopathies
may show some differences in the genetically different
myopathies [15]. Compared to myotilinopathy the
changes in LGMD1D show less frequently tubulofila-
mentous bundles and no basement membrane thicken-
ing, described in myotilinopathy [15]. In zaspopathy
filamentous accumulations in bundles are frequent and
intrasarcoplasmic rods common, but were not observed
in LGMD1D. Desminopathies characteristically show
cytoplasmic electrondense reticular granulofilamentous
accumulations, in addition to areas with sarcomere
disorganization and Z-disk alterations. Areas of
amyloid-like material often adjacent to granulofilamen-
tous inclusions or in vacuolated fibers can also be
found in desminopathy, as well as other myofibrillar
myopathies [8, 16]. Reticular desmin aggregates or
amyloid deposits were not found ultrastructurally in
the studied LGMD1D biopsies. The large complexes of
electrodense granulofilamentous accumulations and
sandwich formations in desminopathy and αB-
crystallinopathy and filamentous bundles and extensive
Z-disk alterations in myotilinopathy and zaspopathy
were not observed ultrastucturally in LGMD1D.
The autophagic degenerative component of the path-
ology in LGMD1D with the basic features of rimmed
vacuoles on light microscopy and disorganized myofi-
brillar structures, Z-line dispersion, and dilatation of
sarcoplasmic reticulum into vacuolar formations on
ultrastructure are not particularly different compared to
the similar pathology of the other myofibrillar myop-
athies or s-IBM. However, eosinophilic inclusions in the
rimmed vacuoles that occasionally may be observed in
s-IBM were rare in the LGMD1D samples.
LGMD1D is caused by mutations in DNAJB6 gene
[10]. DNAJB6 belongs to the evolutionarily conserved
DNAJ / HSP40 family of proteins, which regulate mo-
lecular chaperone activity by stimulating ATPase activity
[17]. DNAJB6 is expressed in many tissues [18] with its
highest expression in brain. Its association to skeletal
muscle disease was shown in 2012 [10]. Our previous
studies suggested DNAJB6 involvement in the CASA
pathway, a major mechanism in protein re-cycling and
turnover for the maintenance of Z-disc sarcomeric
Fig. 3 a, c, d. Vastus lateralis muscle of a 72-year-old female (FF1, III-12): moderate or strong expression of proteins myotilin (a), desmin (c) and
alphaB-crystallin (d) in the myofibrillar lesions with aggregates on immunohistochemistry. b. Congo red staining viewed through Texas-red filters
shows numerous congophilic fluorescent deposits in muscle fibers. e. Dystrophin-2 showed ectopic expression of mild or moderate intensity in
the same regions. f, g, h. The protein accumulations showing CASA complex proteins BAG3 (f), HSPB8 (g), and DNAJB6 (h)
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Table 4 Immunohistochemical findings
Muscle Myotilin α-BC Desmin DYS-2 SMI-31 TDP-43 p62 Ubiquitin LAMP-2 VCP FHL1 Membr prot LC3 HSPB8
FF1
III-6 VL + – –
III-8 S ++ ++ + ++ ++ ++ +
III-12 VL
GLU + +
VL + + + + – – –
IV-7 GM ++ ++ + ++ ++
GM ++ ++ ++ ++ ++ ++ ++ ++ – ++ – ++
IV-8 GM ++ ++ ++ + ++ ++ ++ – – – ++
IV-9 VL – + + + –
VL + + + – ++ ++ –
IV-10 VL ++ ++ + + – + + – –
VL ++ ++ + + – + + ++ – – +
FF2
III-4 VL – –
III-5 VL – – –
III-7 VL + + + +
FF3
IV-1 VL – ++ –
GL ++ ++ ++ + ++ –
FF4
III-2 VL ++ ++ ++ ++ ++ ++ ++ ++ – ++ – ++ +
IV-1 VL + ++ ++
FF5
IV-1 VL ++ ++ + + ++ ++ ++ – – – – +
FF6
IV-1 VL + – + – +/– +/– + + – + – +
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Table 4 Immunohistochemical findings (Continued)
DNAJB6 Ubiquilin2 Cathepsin B Filamin C BAG3 α-actinin Teletonin Actin SERCA α-tubulin SMI310 Proteasome β-amyloid APP WIP1
FF1
+ – – –
++ – – ++ + – ++ + – – –
– – – ++ + – – ++ + – – –
– + – – –
++ + + – – –
– – – – + + – + – – –
FF2
FF3
FF4
+ ++ + – ++ + – +
FF5
+ + ++ – – –
FF6
+ +/– –
–, normal, no immunoreactivity; +, present immunoreactivity; ++, prominent immunoreactivity
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integrity. We have in our previous work found that
DNAJB6 interacts with several members of CASA com-
plex: BAG3, HSPA8, STUB1 and HSPB8 [10]. In this
study we also demonstrate in patient muscle biopsies the
involvement of these proteins, thus confirming the re-
sults shown with the F93I mutation [11]. The dominant
toxic effect of the mutant F93L decreases the anti-
aggregational effect of DNAJB6 and makes the whole
chaperonal complex in which DNAJB6 is involved less
effective, leading to protein aggregations and second-
ary autophagic abnormalities with rimmed vacuolar
pathology. Because of the defective DNAJB6 function
Z-disc components are disturbed and accumulate first
(myotilin, desmin, αB-crystallin, BAG3) followed by
defective autophagy which can be seen as staining of
rimmed vacuolar markers LC3, VCP, TDP-43, SMI-31
and p62 increasing with disease duration. These find-
ings, when observed in the clinical diagnostic praxis,
in particular the early changes of smaller myofibrillar
aggregates in normal sized fibers should direct the
further diagnostic efforts towards DNAJB6 and
LGMD1D disease.
Exceptionally, LGMD1B has been reported to cause
myofibrillar changes similar to LGMD1D, however with-
out rimmed vacuolar pathology [19].
Histopathology of LGMD1D is different from the
other more prevalent autosomal dominant limb-girdle
muscular dystrophies; markedly different from the usu-
ally nonspecific pathology in LGMD1B and LGMD1C
and also distinct from the more closely related
LGMD1A myotilinopathy.
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